| NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
|---|
| 16729-0332 | oxaliplatin | Accord Healthcare Inc. | NO | |
| 45963-0638 | Oxaliplatin | Actavis Pharma, Inc. | YES | 2020-02-29 |
| 45963-0637 | Oxaliplatin | Actavis Pharma, Inc. | YES | 2020-02-29 |
| 45963-0611 | Oxaliplatin | Actavis Pharma, Inc. | YES | 2024-08-31 |
| 47781-0592 | Oxaliplatin | Alvogen Inc. | YES | 2019-12-01 |
| 47781-0591 | Oxaliplatin | Alvogen Inc. | YES | 2019-12-01 |
| 60505-6132 | Oxaliplatin | Apotex Corp. | NO | |
| 60505-6287 | Oxaliplatin | Apotex Corp. | NO | |
| 63323-0650 | oxaliplatin | APP Pharmaceuticals, LLC | YES | No later than 2015-06-29 |
| 63323-0212 | Oxaliplatin | APP Pharmaceuticals, LLC | YES | 2017-05-31 |
| 63323-0211 | Oxaliplatin | APP Pharmaceuticals, LLC | YES | 2016-03-31 |
| 70860-0201 | Oxaliplatin | Athenex Pharmaceutical Division, LLC. | YES | No later than 2022-03-22 |
| 43066-0014 | Oxaliplatin | Baxter Healthcare Corporation | NO | |
| 43066-0018 | Oxaliplatin | Baxter Healthcare Corporation | NO | |
| 68001-0341 | oxaliplatin | BluePoint Laboratories | YES | No later than 2021-09-22 |
| 68001-0468 | Oxaliplatin | BluePoint Laboratories | NO | |
| 51991-0923 | Oxaliplatin | Breckenridge Pharmaceutical, Inc. | YES | 2019-05-31 |
| 51991-0922 | Oxaliplatin | Breckenridge Pharmaceutical, Inc. | YES | 2019-05-31 |
| 51991-0219 | Oxaliplatin | Breckenridge Pharmaceutical, Inc. | YES | 2020-10-31 |
| 51991-0218 | Oxaliplatin | Breckenridge Pharmaceutical, Inc. | YES | 2020-10-31 |
| 69097-0274 | oxaliplatin | Cipla USA Inc. | YES | No later than 2022-12-30 |
| 69097-0353 | oxaliplatin | Cipla USA Inc. | YES | No later than 2022-12-30 |
| 55150-0332 | Oxaliplatin | Eugia US LLC | NO | |
| 55150-0331 | Oxaliplatin | Eugia US LLC | NO | |
| 72266-0162 | Oxaliplatin | FOSUN PHARMA USA INC. | NO | |
| 72266-0161 | Oxaliplatin | FOSUN PHARMA USA INC. | NO | |
| 72266-0125 | Oxaliplatin | Fosun Pharma USA Inc. | YES | No later than 2024-06-26 |
| 72266-0126 | Oxaliplatin | Fosun Pharma USA Inc. | YES | No later than 2024-06-26 |
| 63323-0750 | Oxaliplatin | Fresenius Kabi USA, LLC | NO | |
| 68083-0314 | Oxaliplatin | Gland Pharma Limited | NO | |
| 68083-0176 | Oxaliplatin | Gland Pharma Limited | NO | |
| 68083-0171 | Oxaliplatin | Gland Pharma Limited | NO | |
| 68083-0170 | Oxaliplatin | Gland Pharma Limited | NO | |
| 68083-0177 | Oxaliplatin | Gland Pharma Limited | NO | |
| 61703-0361 | Oxaliplatin | Hospira, Inc. | YES | No later than 2017-12-29 |
| 61703-0362 | Oxaliplatin | Hospira, Inc. | YES | No later than 2017-12-29 |
| 61703-0363 | Oxaliplatin | Hospira, Inc. | NO | |
| 50742-0406 | Oxaliplatin | Ingenus Pharmaceuticals, LLC | NO | |
| 50742-0405 | Oxaliplatin | Ingenus Pharmaceuticals, LLC | NO | |
| 71288-0101 | Oxaliplatin | Meitheal Pharmaceuticals Inc. | YES | 2027-02-28 |
| 71288-0172 | Oxaliplatin | Meitheal Pharmaceuticals Inc. | NO | |
| 71288-0149 | Oxaliplatin | Meitheal Pharmaceuticals Inc. | YES | 2027-02-28 |
| 71288-0171 | Oxaliplatin | Meitheal Pharmaceuticals Inc. | NO | |
| 67457-0476 | Oxaliplatin | Mylan Institutional LLC | YES | No later than 2018-03-29 |
| 67457-0468 | Oxaliplatin | Mylan Institutional LLC | YES | No later than 2018-03-29 |
| 67457-0469 | Oxaliplatin | Mylan Institutional LLC | NO | |
| 67457-0442 | Oxaliplatin | Mylan Institutional LLC | NO | |
| 79672-0825 | Oxaliplatin | Nextgen Pharmaceuticals LLC | NO | |
| 79672-0826 | Oxaliplatin | Nextgen Pharmaceuticals LLC | NO | |
| 79672-0019 | Oxaliplatin | Nextgen Pharmaceuticals LLC | YES | No later than 2020-12-31 |
| 79672-0018 | Oxaliplatin | Nextgen Pharmaceuticals LLC | YES | No later than 2020-12-31 |
| 72603-0301 | Oxaliplatin | NorthStar Rx LLC | NO | |
| 72603-0320 | Oxaliplatin | Northstar Rx LLC | NO | |
| 72603-0101 | Oxaliplatin | NorthStar Rx LLC | NO | |
| 72603-0420 | Oxaliplatin | Northstar Rx LLC | NO | |
| 16714-0728 | oxaliplatin | NorthStar RxLLC | YES | No later than 2022-06-28 |
| 16714-0727 | oxaliplatin | NorthStar RxLLC | YES | No later than 2022-06-28 |
| 00069-0074 | Oxaliplatin | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2017-12-29 |
| 00069-1010 | OXALIPLATIN | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2018-06-28 |
| 00069-0067 | OXALIPLATIN | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2018-06-28 |
| 00069-0070 | Oxaliplatin | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2017-12-29 |
| 67184-0509 | Oxaliplatin | Qilu Pharmaceutical Co., Ltd. | NO | |
| 67184-0508 | Oxaliplatin | Qilu Pharmaceutical Co., Ltd. | NO | |
| 67184-0501 | Oxaliplatin | Qilu Pharmaceutical Co., Ltd. | NO | |
| 67184-0502 | Oxaliplatin | Qilu Pharmaceutical Co., Ltd. | NO | |
| 67184-0510 | Oxaliplatin | Qilu Pharmaceutical Co., Ltd. | NO | |
| 25021-0233 | oxaliplatin | Sagent Pharmaceuticals | NO | |
| 25021-0211 | oxaliplatin | Sagent Pharmaceuticals | YES | No later than 2017-12-29 |
| 25021-0212 | oxaliplatin | Sagent Pharmaceuticals | YES | No later than 2017-12-29 |
| 00781-9317 | Oxaliplatin | Sandoz Inc | NO | |
| 00781-9315 | Oxaliplatin | Sandoz Inc | NO | |
| 00781-3315 | Oxaliplatin | Sandoz Inc | NO | |
| 00781-3317 | Oxaliplatin | Sandoz Inc | NO | |
| 57277-0001 | Oxaliplatin | Sanja Pharmaceuticals Company | YES | No later than 2019-12-28 |
| 57277-0002 | Oxaliplatin | Sanja Pharmaceuticals Company | YES | No later than 2019-12-28 |
| 47335-0046 | Oxaliplatin | Sun Pharmaceutical Industries, Inc. | YES | No later than 2020-04-01 |
| 47335-0047 | Oxaliplatin | Sun Pharmaceutical Industries, Inc. | YES | No later than 2020-04-01 |
| 47335-0178 | Oxaliplatin | Sun Pharmaceutical Industries, Inc. | YES | No later than 2020-04-01 |
| 47335-0176 | Oxaliplatin | Sun Pharmaceutical Industries, Inc. | YES | No later than 2020-04-01 |
| 00703-3986 | Oxaliplatin | Teva Parenteral Medicines, Inc. | YES | 2026-03-31 |
| 00703-3985 | Oxaliplatin | Teva Parenteral Medicines, Inc. | YES | 2026-03-31 |
| 00955-1725 | OXALIPLATIN | Winthrop U.S, a business of sanofi-aventis U.S. LLC | YES | No later than 2025-09-22 |
| 00955-1727 | OXALIPLATIN | Winthrop U.S, a business of sanofi-aventis U.S. LLC | YES | No later than 2025-03-24 |
| 00955-1731 | OXALIPLATIN | Winthrop U.S, a business of sanofi-aventis U.S. LLC | NO | |
| 00955-1733 | OXALIPLATIN | Winthrop U.S, a business of sanofi-aventis U.S. LLC | NO | |